Status:

ACTIVE_NOT_RECRUITING

Alpha-1 Antitrypsin Disease Cohort: Longitudinal Biomarker Study of Disease

Lead Sponsor:

Columbia University

Collaborating Sponsors:

Alpha-1 Foundation

National Heart, Lung, and Blood Institute (NHLBI)

Conditions:

Alpha 1-Antitrypsin Deficiency

Genetic Disease

Eligibility:

All Genders

18+ years

Brief Summary

Alpha-1 Anti-trypsin Deficiency (AATD) is a genetic disease with lung and liver disease presentations. The purpose of this study is to examine the density of the lung as measured by chest computed tom...

Detailed Description

Progression of lung disease in patients with Alpha-1 Anti-trypsin deficiency is variable and while some patients may have stable lung function over many years, some progress and deteriorate rapidly. C...

Eligibility Criteria

Inclusion

  • Males and females aged 18 years and older
  • Patients with known Alpha-1 Anti-trypsin deficiency (PiZZ)
  • Be an existing member of the Alpha-1 Foundation Clinical Cohort (Alpha-1 Foundation Research Registry)
  • Willingness to perform study procedures of Chest CT, blood biomarker determination, questionnaire completion, and lung function testing.

Exclusion

  • AATD non-PiZZ status, including carriers
  • Pregnancy at the time of the screening visit
  • COPD exacerbation or other pulmonary infection within 6 weeks of baseline visit
  • Previous lung or liver transplantation or currently on the transplant list

Key Trial Info

Start Date :

March 23 2022

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

January 1 2027

Estimated Enrollment :

286 Patients enrolled

Trial Details

Trial ID

NCT05297812

Start Date

March 23 2022

End Date

January 1 2027

Last Update

December 13 2024

Active Locations (9)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (9 locations)

1

University of Alabama at Birmingham

Birmingham, Alabama, United States, 35233

2

University of California - Los Angeles

Los Angeles, California, United States, 90095

3

National Jewish Health

Denver, Colorado, United States, 80206

4

University of Chicago

Chicago, Illinois, United States, 60637